help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology, doi:10.1210/en.2006-1678
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
148/5/2505    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meffre, D.
Right arrow Articles by Guennoun, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meffre, D.
Right arrow Articles by Guennoun, R.
Endocrinology Vol. 148, No. 5 2505-2517
Copyright © 2007 by The Endocrine Society

Steroid Profiling in Brain and Plasma of Male and Pseudopregnant Female Rats after Traumatic Brain Injury: Analysis by Gas Chromatography/Mass Spectrometry

D. Meffre1, A. Pianos1, P. Liere, B. Eychenne, A. Cambourg, M. Schumacher, D. G. Stein and R. Guennoun

Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche 788 (D.M., A.P., P.L., B.E., A.C., M.S., R.G.), Steroids, Neuroprotection, and Neuroregeneration, and University Paris 11, 94276 Kremlin-Bicêtre, France; and Brain Research Laboratory (D.G.S.), Department of Emergency Medicine, Emory University, Atlanta, Georgia 30322

Address all correspondence and requests for reprints to: Dr. R. Guennoun, Institut National de la Santé et de la Recherche Médicale UMR788, 80 Rue du Général Leclerc, 94276 Bicêtre, France. E-mail: guennoun{at}kb.inserm.fr.


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Steroids in brain arise from the peripheral endocrine glands and local synthesis. In traumatic brain injury (TBI), the endogenous circulating hormones at the time of injury are important for neuroprotection. In particular, pseudopregnant females recover better than males from TBI. We investigated the effect of pseudopregnancy and TBI on steroid levels in plasma and in three brain regions (within, adjacent, and distal to the lesion site), 6 and 24 h after prefrontal cortex injury. The following steroids were analyzed by gas chromatography/mass spectrometry: pregnenolone, progesterone, 5{alpha}-dihydroprogesterone, 3{alpha},5{alpha}-tetrahydroprogesterone, 3ß,5{alpha}-tetrahydroprogesterone, dehydroepiandrosterone, {Delta}4-androstenedione, testosterone, 5{alpha}-dihydrotestosterone, 3{alpha},5{alpha}-tetrahydrotestosterone, 3ß,5{alpha}-tetrahydrotestosterone, and 17ß-estradiol. Corticosterone was assayed in plasma to account for stress in the rats. We found different steroid profiles in brain and plasma of male and pseudopregnant female rats and specific profile changes after TBI. In sham-operated pseudopregnant females, much higher levels of progesterone, 5{alpha}-dihydroprogesterone, 3{alpha},5{alpha}-tetrahydroprogesterone, and 3ß,5{alpha}-tetrahydroprogesterone were measured in both brain and plasma, compared with sham-operated males. Plasma levels of corticosterone were high in all groups, indicating that the surgeries induced acute stress. Six hours after TBI, the levels of pregnenolone, progesterone, and 5{alpha}-dihydroprogesterone increased, and those of testosterone decreased in male brain, whereas levels of 5{alpha}-dihydroprogesterone and 3ß,5{alpha}-tetrahydroprogesterone increased in brain of pseudopregnant female rats. Plasma levels of 5{alpha}-dihydroprogesterone did not change after TBI, suggesting a local activation of the 5{alpha}-reduction pathway of progesterone in both male and pseudopregnant female brain. The significant increase in neurosteroid levels in the male brain after TBI is consistent with their role in neuroprotection. In pseudopregnant females, high levels of circulating progestagens may provide protection against TBI.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
THE NERVOUS SYSTEM is an important target of steroid hormones. The mechanisms by which these steroids exert their effects were construed as a classical endocrine mechanism involving production by endocrine glands, secretion into the bloodstream, crossing of the blood-brain barrier, and then regulation of central nervous system (CNS) functions (1, 2, 3). A further advance was the finding that androgens act in the CNS after their local conversion into estrogens by aromatization (4). Finally, the discovery of the local de novo synthesis of neurosteroids from cholesterol in the nervous system (5) has added paracrine and/or autocrine mechanisms to the list of ways by which steroids can regulate brain functions. The CNS can synthesize steroids as well as take them up from the blood. Thus, steroid brain concentrations are in part related to their peripheral production in endocrine organs. Figure 1Go summarizes the main pathways of steroidogenesis. All steroids are derived from cholesterol. The cytochrome P450 side-chain cleavage enzyme is involved in the conversion of cholesterol to pregnenolone (PREG). PREG can be converted either to progesterone (PROG) by the 3ß-hydroxysteroid dehydrogenase/{Delta}5-{Delta}4 isomerase (3ß-HSD), or to dehydroepiandrosterone (DHEA) by the P450c17 enzyme. PROG is a key hormone that gives rise to all the other steroid hormones. Indeed, PROG can be converted to 11-deoxycorticosterone by the P450c21 enzyme and then to corticosterone by P45011ß. PROG can also be metabolized to {Delta}4-androstenedione by the P450c17 enzyme and then to testosterone by the 17ß-hydroxysteroid dehydrogenase enzyme. Testosterone can be converted to 17ß-estradiol by the aromatase. In addition, PROG and testosterone can be converted respectively to 5{alpha}-dihydroprogesterone (5{alpha}-DHPROG) and to 5{alpha}-dihydrotestosterone (5{alpha}-DHT) by the steroid 5{alpha}-reductases (two distinct isozymes 1 and 2) and then to 3{alpha},5{alpha}-tetrahydroprogesterone (3{alpha},5{alpha}-THPROG) and 3{alpha},5{alpha}-tetrahydrotestosterone (3{alpha},5{alpha}-THT) by the 3{alpha}-hydroxysteroid oxidoreductase (3{alpha}-HSD). In addition, 5{alpha}-DHPROG and 5{alpha}-DHT can be reduced, respectively, to 3ß,5{alpha}-tetrahydroprogesterone (3ß,5{alpha}-THPROG) and 3ß,5{alpha}-tetrahydrotestosterone (3ß,5{alpha}-THT) by the 3ß-hydroxysteroid oxidoreductase (3ß-HSOR).


Figure 1
View larger version (16K):
[in this window]
[in a new window]

  		FIG. 1. Pathways of steroidogenesis. The abbreviated name of the enzyme involved for each reaction is indicated. Steroids included: 3{alpha},5{alpha}-THPROG, 5{alpha}-DHPROG (5{alpha}-dihydroprogesterone). Enzymes included: 3{alpha}-HSD, 3ß-HSD/{Delta}5-{Delta}4 isomerase, 3ß-HSOR, 17ß-HSD (17ß-hydroxysteroid dehydrogenase), P450c11ß (11ß-hydroxylase), P450c17 (17{alpha}-hydroxylase/C17–20-lyase), P450c21 (21-hydroxylase), P450scc (cytochrome P450 side-chain cleavage).

 
It is now clear that PROG and its reduced metabolites (5{alpha}-DHPROG and 3{alpha},5{alpha}-THPROG), and estrogens exert a variety of neuroprotective effects and that they may be good candidates for therapeutic tools after spinal cord and brain injuries and in neurodegenerative diseases (6, 7, 8, 9, 10, 11, 12). A recent phase II clinical trial with PROG in patients with moderate to severe traumatic brain injury (TBI) revealed that 3 d of treatment with PROG could reduce mortality by more than 50% in the severely injured group (13).

Initial evidence that PROG could be used as a pharmacological agent after brain injury came from studies on gender differences in recovery, which also suggested that endogenous levels of PROG could enhance recovery of function from TBI (14). Indeed, high levels of endogenous PROG promote behavioral recovery and decrease the cytotoxic sequel of trauma. For example, compared with males, postinjury edema is lower in normal-cycling females and practically eliminated in pseudopregnant females (a hormonal state in which PROG levels remain high for about 10 d after cervical stimulation) after medial frontal cortical contusions (15). Not only does treatment with exogenous steroids decrease the response to various forms of insult, but also endogenous levels at the time of injury are important for neuroprotection (7, 8). Furthermore, the nervous system itself may adjust and adapt both steroid synthesis and steroid receptor expression after injury, as we have demonstrated for the brain and spinal cord (16, 17). One important question is the impact of the steroids either produced by peripheral steroidogenic organs or pharmacologically administered on steroid synthesis by the CNS. Castration and adrenalectomy had no effects on 3ß-HSD expression in spinal cord (18) whereas estrogen treatment increased 3ß-HSD expression and activity in the hypothalamus of female rats (19). Progesterone synthesis has been shown to be stimulated by estradiol in the hypothalamus and enriched astrocyte cultures (19, 20, 21). Variation in the production of PROG from peripheral glands could influence levels of brain PROG and its metabolites. Indeed, PROG originating in the periphery is taken up by the brain in considerable amounts (22), and the conversion of PROG to its neuroactive metabolites takes place within the brain (12, 23, 24, 25). Apart from being a substrate for this metabolism, PROG exerts its own hormonal effects through specific receptors.

Because pseudopregnant females have better outcomes than males and steroids have neuroprotective effects after TBI, we examined the local modifications of steroid levels in males and pseudopregnant females after TBI to gain insight into the hormonal determination of neuroprotection. First, we compared steroid levels between male and pseudopregnant female rats to evaluate how variations in plasma concentrations of steroids are reflected in brain. Second, we investigated the effect of TBI on steroid levels in plasma and three brain regions (within, adjacent to, and distal to the lesion site) to evaluate how hormonal state at the time of injury could affect the response of the nervous tissue to injury.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Subjects
Adult male and female Sprague Dawley rats approximately 90 d of age at the beginning of the experiment were housed individually and kept on a reverse light-dark cycle (0800–2000 h). All procedures concerning animal care and use were carried out in accordance with the European Community Council Directive (86/609/EEC) and conformed to guidelines set forth in the Guide for the Care and Use of Laboratory Animals (National Academy of Sciences, 1996), and were approved by the Emory University Institutional Animal Care and Use Committee, protocol 098-2001.

Pseudopregnancy induction
Vaginal lavages were used to determine the time of pseudopregnancy induction and confirm that rats were pseudopregnant at the time of injury. Lavages were collected and analyzed daily beginning 1 d after the rat’s arrival in the laboratory and continued through the day of surgery. The epithelium of the vagina was flushed with saline solution (0.9%) using a blunt-end plastic pipette and then dispersing the pipette’s contents onto a clean microscope slide. The samples were analyzed under a light microscope and the cell types present (leukocytes, nucleated epithelial cells, and/or cornified epithelial cells) were recorded. The stage in the estrous cycle (metestrus, diestrus, proestrus, or estrus) at the time of the lavage was determined based on the presence or absence of these cell types. Pseudopregnancy was induced 5 d before surgery by stimulating the cervix mechanically using the soft, rubber-tipped plunger of a plastic 1-cc syringe for 1 min when females were in estrus and exhibiting cornified cells (15).

Animals and experimental injury model (Fig. 2AGo)
Eight groups of rats were prepared (n = 6 or 7/group): four conditions (sham-operated males, males with TBI, sham-operated pseudopregnant females, and pseudopregnant females with TBI) and two times of analysis (6 and 24 h after surgery) were chosen to profile steroid levels in brain and plasma. The controlled cortical impact injury for the females was done on their fifth day of pseudopregnancy, when they were exhibiting abundant leukocytes. Surgery for an equal number of males was done when females were to be injured. Bilateral contusions of the medial prefrontal cortex of male and pseudopregnant female rats were made with a pneumatic impactor device (see Ref. 26 for details). Briefly, animals were anesthetized with ketamine/xylazine (90 mg/kg per 10 mg/kg) and placed in a stereotaxic apparatus equipped with a homeothermic blanket system to maintain body core temperature at 37 C. A midline incision was made in the scalp, the fascia was retracted to expose the cranium, and a craniectomy (6 mm diameter) was made over the midline of the prefrontal cortex with its center 3.0 mm anteroposterior to bregma. After removal of the bone, the tip of the impactor (5 mm diameter) was moved to +3.0 mm anteroposterior, 0.0 mm (from bregma), and checked for adequate clearance. Trauma was produced by activating the piston with compressed air to impact –2.0 mm dorsoventral (from dura) at a velocity of 2.25 m/sec with a brain contact time of 0.5 sec. After the contusion injury, the wound cavity was cleaned and bleeding stopped before scalps were sutured. Sham-operated animals sustained the anesthesia, incision, and suture of the scalp.


Figure 2
View larger version (15K):
[in this window]
[in a new window]

  		FIG. 2. Experimental groups and samples used for steroid analysis by GC/MS. A, Summary of experimental groups and time course of the pseudopregnancy induction and injury. Eight groups were used: sham-operated males, males with TBI, sham-operated pseudopregnant females, and pseudopregnant females with TBI; with two times of analysis, 6 and 24 h after injury. CCI, Controlled cortical impact; n, number of animals per group; psg, pseudopregnancy; SMP, sampling. B, Location of the samples taken for steroid determination. In addition to the plasma, three brain regions were collected from each animal: contused tissue (L), bilateral samples adjacent to the lesion (AL), and bilateral samples from posterior cortex (DL).

 
Samples for steroid determination
Rats were killed by decapitation 6 and 24 h after surgery. For each rat, four samples were collected. A sample from cardiac blood was taken and the brain dissected out of the skull on a bed of crushed ice. Three brain regions were collected from each brain (Fig. 2BGo): contused tissue [lesion site (L)], bilateral samples adjacent to the lesion [adjacent to the lesion (AL)], and bilateral samples from posterior cortex [distal to the lesion (DL)]. Brain samples were weighed, frozen on dry ice, and stored at –80 C until gas chromatography coupled to mass spectrometry (GC/MS) analysis.

Measurement of steroid levels by GC/MS
PREG, PROG, 5{alpha}-DHPROG, 3{alpha},5{alpha}-THPROG, 3ß,5{alpha}-THPROG, {Delta}4-androstenedione, testosterone, 5{alpha}-DHT, 3{alpha},5{alpha}-THT, 3ß,5{alpha}-THT, DHEA, and 17ß-estradiol levels were determined by GC/MS according to the protocol described by Liere et al. (27) with minor modifications. Briefly, steroids were extracted from individual brain regions (the weight range was 93–450 mg of tissue) and plasmas (1 ml) by adding 10 volumes of methanol. Corticosterone was measured only in plasmas 6 and 24 h after injury to document the stress state of the animals. The internal standards epietiocholanolone (for PREG, 3{alpha},5{alpha}-THPROG, 3ß,5{alpha}-THPROG, {Delta}4-androstenedione, testosterone, 5{alpha}-DHT, 3{alpha},5{alpha}-THT, 3ß,5{alpha}-THT, DHEA, and 17ß-estradiol), 19-nor PROG (for PROG), 2H6-5{alpha}-DHPROG (for 5{alpha}-DHPROG), and 2H8-corticosterone (for corticosterone) were introduced into the extract for steroid quantification. Samples were purified and fractionated by solid-phase extraction with the recycling procedure (28) and HPLC as previously described (16). Three fractions were collected from the HPLC system: 5{alpha}-DHPROG and 2H6-5{alpha}-DHPROG were eluted in the first HPLC fraction (3–10 min) and were silylated with N-methyl-N-trimethylsilyltrifluoroacetamide/NH4I/dithioerythritol (1000:2:5 vol/vol/vol) for 15 min at 70 C. The second fraction (10–31 min) contained PREG, PROG, 3{alpha},5{alpha}-THPROG, 3ß,5{alpha}-THPROG, {Delta}4-androstenedione, testosterone, 5{alpha}-DHT, 3{alpha},5{alpha}-THT, 3ß,5{alpha}-THT, DHEA, 17ß-estradiol, epietiocholanolone, and 19-nor PROG. Corticosterone and its internal standard 2H8-corticosterone were eluted in the third HPLC fraction (31–45 min). These two latter fractions were derivatized with heptafluorobutyric anhydride in anhydrous acetone for 30 min at 20 C. All the fractions were dried under a stream of N2 and resuspended in hexane for GC/MS analysis.

Calibration and biological samples were analyzed by GC/MS with an AS 2000 autosampler (Carlo Erba, Milan, Italy). The TraceGC gas chromatograph (Carlo Erba) is coupled with an Automass Solo mass spectrometer (Thermo Electron, Les Ulis, France). Injection was performed in the splitless mode at 250 C (1 min of splitless time), and the temperature of the gas chromatograph oven was initially maintained at 50 C for 1 min and then ramped between 50 and 340 C at 20 C/min. The helium carrier gas flow was maintained constant at 1 ml/min during the analysis. The transfer line and ionization chamber temperatures were 300 and 180 C, respectively. Electron impact ionization was used for mass spectrometry with an ionization energy of 70 eV. Identification of each steroid was supported by its retention time and its two diagnostic ions (see Table 1Go). Quantification was performed in single ion monitoring (SIM) mode according to the major diagnostic ion, called quantification ion, and to the retention time of each derivatized steroid.


View this table:
[in this window]
[in a new window]

  		TABLE 1. GC/MS parameters used for steroid identifications in SIM detection

 
The analytical protocol has been previously validated (16) for PREG, PROG, and their reduced metabolites. The same experimental procedure was applied to validate the quantification of DHEA, testosterone, 5{alpha}-DHT, 3{alpha},5{alpha}-THT, 3ß,5{alpha}-THT, {Delta}4-androstenedione, 17ß-estradiol, and corticosterone. Only testosterone could be detected in all the aliquots of extracts from an adult male brain (10, 20, 50, 100, 200, and 300 mg). DHEA and 3{alpha},5{alpha}-THT were detected only in 300 mg of brain extract. In male rat plasma, testosterone and 3{alpha},5{alpha}-THT were detected in all the plasma extracts (50, 100, 200, 500, 1000 µl) and {Delta}4-androstenedione and 5{alpha}-DHT could be detected from 1 ml of plasma. The overall results of validation are summarized in Table 2Go in terms of basal values, coefficient of variation, coefficient of correlation, and limit of detection in plasma (1 ml) and brain (100 mg).


View this table:
[in this window]
[in a new window]

  		TABLE 2. Validation of steroid measurements in male rat brain and plasma by GC/MS

 
Statistical analysis
All data were analyzed by a commercially available program (GraphPad Prism 3.0; GraphPad Inc., San Diego, CA). For brain samples, data were processed using two-way ANOVA (treatment x region), followed by Bonferroni post hoc test. For plasma samples, Student’s t test was used. Statistical significance was noted when the probability of type I error was less than 0.05.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Steroid profiles in brain regions and plasma of sham-operated male and pseudopregnant female rats
The different steroids were found in a very wide range of concentrations in brain and plasma of sham-operated male and pseudopregnant female rats (Figs. 3–5GoGoGo, white bars). In sham-operated males, the decreasing order of mean concentrations was: PREG > PROG {approx} testosterone > 5{alpha}-DHPROG = 5{alpha}-DHT > 3{alpha},5{alpha}-THT = {Delta}4-androstenedione in brain and PROG > PREG = testosterone > 5{alpha}-DHPROG > {Delta}4-androstenedione {approx} 3{alpha},5{alpha}-THT > 5{alpha}-DHT in plasma (Figs. 3Go and 4Go, white bars). In sham-operated pseudopregnant females, the decreasing order of concentrations was: PROG {approx} 5{alpha}-DHPROG > PREG ≥ 3{alpha},5{alpha}-THPROG > 3ß,5{alpha}-THPROG in brain and PROG > 5{alpha}-DHPROG {approx} 3{alpha},5{alpha}-THPROG ≥ PREG > 3ß,5{alpha}-THPROG in plasma (Fig. 5Go, white bars). In both plasma and brain, the concentrations of PROG and its metabolites were much higher in pseudopregnant females than males. The levels of 5{alpha}-DHPROG in the pseudopregnant female rats were about 10 times higher in brain, compared with plasma, suggesting that most of the reduction of PROG takes place in the brain itself. Furthermore, we calculated the ratio of reduced PROG metabolites (5{alpha}-DHPROG, 3{alpha},5{alpha}-THPROG, and 3ß,5{alpha}-THPROG) to PROG in brain and plasma to provide an index of the conversion of the parent hormone PROG to its reduced metabolites. This ratio was 5–8 times higher in brain than plasma, further supporting the hypothesis that the reduced metabolites of PROG detected in pseudopregnant female rat brain are very likely locally synthesized and that only a minor part is derived from the circulation. Whereas testosterone, its precursor, and its 5{alpha}-reduced metabolites were detectable in male brain and plasma, no trace of these androgens was detected in pseudopregnant female samples. 17ß-estradiol levels were below the limit of detection in brain and plasma of male and pseudopregnant female rats.


Figure 3
View larger version (19K):
[in this window]
[in a new window]

  		FIG. 3. Steroid levels in brain and plasma of adult male rats 6 and 24 h after sham operation or TBI. Concentrations of PREG, PROG, and 5{alpha}-DHPROG in three brain regions (L, AL, DL) and plasma. White bars, Levels for sham-operated rats; black bars, effect of TBI. Data represent mean ± SEM of six rats. Statistical analysis: two-way ANOVA for brain; Student’s t test for plasma samples. **, P < 0.01; ****, P < 0.0001.

 

Figure 4
View larger version (19K):
[in this window]
[in a new window]

  		FIG. 4. Steroid levels in brain and plasma of adult male rats 6 and 24 h after sham operation or TBI. Concentrations of {Delta}4-androstenedione, testosterone, 5{alpha}-DHT, and 3{alpha},5{alpha}-THT in three brain regions (L, AL, DL) and plasma. White bars, Levels for sham-operated rats; black bars, effect of TBI. Data represent mean ± SEM of six rats. Statistical analysis: two-way ANOVA for brain; Student’s t test for plasma samples. *, P < 0.05; **, P < 0.01; ****, P < 0.0001.

 

Figure 5
View larger version (20K):
[in this window]
[in a new window]

  		FIG. 5. Steroid levels in brain and plasma of pseudopregnant (Psg) female rats 6 and 24 h after sham operation or TBI. Concentrations of PREG, PROG, 5{alpha}-DHPROG, 3{alpha},5{alpha}-THPROG, and 3ß,5{alpha}-THPROG in three brain regions (L, AL, DL) and plasma. White bars, Levels for sham-operated rats; black bars, effect of TBI. Data represent mean ± SEM of six to seven rats. Statistical analysis: two-way ANOVA and Student’s t test for brain samples; Student’s t test for plasma samples. *, P < 0.05; **, P < 0.01; ****, P < 0.0001.

 
Effects of TBI on steroid levels in plasma and brain of male and pseudopregnant female rats: analysis by GC/MS 6 and 24 h after injury
Males (Figs. 3Go and 4Go).
Two-way ANOVA (treatment x region) revealed a significant effect of the lesion on levels of PREG (F1,29 = 10.36; P < 0.01), PROG (F1,28 = 10.47; P < 0.01), 5{alpha}-DHPROG (F1,30 = 31.86; P < 0.0001), and testosterone (F1,29 = 43.49; P < 0.0001) in brain 6 h after TBI. The subsequent Bonferroni post hoc test showed that the levels of PREG increased in L (+75%, P < 0.05). The levels of PROG tended to increase in the different brain regions, but the differences were not statistically significant. The levels of 5{alpha}-DHPROG increased in L (+189%, P < 0.001) and the posterior cortex DL (+145%, P < 0.05). Changes in plasma levels of PREG, PROG, and 5{alpha}-DHPROG were not statistically significant. The levels of 3{alpha},5{alpha}-THPROG and 3ß,5{alpha}-THPROG were still below the threshold of detection in both brain (<1.0 and 0.25 ng/g, respectively) and plasma (<1.0 and 0.02 ng/ml, respectively). Testosterone levels decreased dramatically in the lesion site (–82%, P < 0.01), in the tissue AL (–85%, P < 0.01), posterior cortex DL (–86%, P < 0.001), and plasma (–84%, P < 0.01). No change in brain levels of {Delta}4-androstenedione, 5{alpha}-DHT, or 3{alpha},5{alpha}-THT was observed in brain samples. However, {Delta}4-androstenedione and 3{alpha},5{alpha}-THT levels decreased significantly in plasma (–85%, P < 0.05 and –68%, P < 0.01, respectively). Twenty-four hours after TBI, the differences in steroid levels between sham-operated and injured rats were not significant, except for PREG levels, which are increased in the brain (F1,30 = 8,51; P < 0.01).

Pseudopregnant females (Fig. 5Go).
Two-way ANOVA (treatment x region) revealed a significant effect of the lesion on the levels of 5{alpha}-DHPROG (F1,30 = 9.73; P < 0.01) and 3ß,5{alpha}-THPROG (F1,29 = 22.72; P < 0.0001) in brain 6 h after TBI. The subsequent Bonferroni post hoc test for brain samples showed that the levels of 5{alpha}-DHPROG increased in the L (+59%, P < 0.01). The levels of 3ß,5{alpha}-THPROG increased in the L (+67%, P < 0.05) and posterior cortex DL (+77%, P < 0.01). The levels of screened androgens and 17ß-estradiol were below the threshold of detection. Plasma levels of all the measured steroids did not change, except for the levels of PROG, which decreased (–41.5%, P < 0.05). Twenty-four hours after TBI, the differences in steroid levels between sham-operated and injured rats were not significant, except for PREG levels, which are increased in the brain (F1,36 = 9,52; P < 0.01) and plasma (+105%, P < 0.05).

Corticosterone levels (Fig. 6Go).
The levels of corticosterone were measured in plasma of sham-operated and injured male and pseudopregnant female rats 6 and 24 h after TBI to evaluate the extent of stress induced by the surgery. High levels of corticosterone were detected in plasma of all groups. These levels were higher in pseudopregnant females than males. In addition, these levels were higher after TBI, particularly in male rats 6 h after TBI (+105%, P < 0.05).


Figure 6
View larger version (8K):
[in this window]
[in a new window]

  		FIG. 6. Corticosterone levels in plasma of male and pseudopregnant (Psg) female rats 6 and 24 h after sham operation or TBI. White bars, Levels for sham-operated rats; black bars, effect of TBI. Data represent mean ± SEM of six to seven rats. Statistical analysis: Student’s t test. *, P < 0.05.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
Our results showed different steroid profiles in brain and plasma of male and pseudopregnant female rats and transitory-specific changes after TBI. Steroids in brain have profound physiological effects that depend on their concentrations in the target tissues, their metabolism, and the distribution of receptors they activate or modulate. Because the different steroids are metabolically linked, changes in the endogenous levels of specific steroids may reflect in vivo regulation of their biosynthesis and metabolism, which in turn may provide insights into their physiological roles.

Sham-operated rats: comparison between males and pseudopregnant females
In this study, very high levels of PROG were measured in the brain of pseudopregnant females, compared with males, reflecting their respective levels in plasma. Indeed, the brain levels of PROG in pseudopregnant females were 47–100 times higher than those measured in males. Thus the concentration of PROG in rat brain is related to endocrine status in males and females, indicating that plasma levels determine the uptake of PROG into the brain. The concentration of PROG and its reduced metabolites in rat and human brain have been reported to be related to endocrinological status. In female rat brain, the levels of PROG, 5{alpha}-DHPROG, and 3{alpha},5{alpha}-THPROG increased during pregnancy (29). In human female brain, the concentrations of the three steroids were significantly higher in the luteal phase, compared with postmenopausal controls. The correlation between serum and brain tissue concentrations indicates that the serum levels are directly related to the uptake of PROG in the brain (30). Because circulating PROG levels are high in pseudopregnant females, the final brain levels represent a high amount of substrate for the 5{alpha}-reductases, leading to increased levels of 5{alpha}-DHPROG, which in turn is a substrate of 3{alpha}-HSD and 3ß-HSOR. Thus, detectable levels of 3{alpha},5{alpha}-THPROG and 3ß,5{alpha}-THPROG were found in brain regions of pseudopregnant females, whereas the two PROG metabolites were below detection limit in brain regions of the sham-operated males. Cheney et al. (31) reported low levels of 3{alpha},5{alpha}-THPROG in male rat brain (0.9 ng/g), and more recently Ebner et al. (32) reported very low levels of 3{alpha},5{alpha}-THPROG (0.35 ng/g) and 3ß,5{alpha}-THPROG (0.13 ng/g) in male rat brain.

The difference between our results and these reports could be due to a difference in the sensitivity of the techniques, the size of the samples used for measurements, or regional heterogeneity in the brain content of these PROG metabolites. Indeed, in the above cited studies, measurements were done in whole brain, whereas we measured steroids in three discrete, specific regions as indicated in Fig. 2Go. Furthermore, we performed measurements in sham-operated male rats, whereas they performed them in control rats. In any case, the levels of 3{alpha},5{alpha}-THPROG and 3ß,5{alpha}-THPROG in sham-operated pseudopregnant females brain were higher than those in sham-operated male rats (the present study) and control male rat brain (31, 32). The 3ß,5{alpha}-THPROG measured in plasma and brain of pseudopregnant female rats could have arisen directly from 5{alpha}-DHPROG or through epimerization of 3{alpha},5{alpha}-THPROG (33).

Comparison of PROG and 5{alpha}-DHPROG levels in sham-operated pseudopregnant females at 6 and 24 h after surgery corresponding to the fifth and sixth day of pseudopregnancy suggests that the 5{alpha}-reduction is an active metabolic pathway in the pseudopregnant female brain. Indeed, on the fifth day of pseudopregnancy (6 h after TBI), PROG levels in the brain were at least two times higher than those of 5{alpha}-DHPROG, whereas they were lower on the sixth day of pseudopregnancy (24 h after TBI).

We noticed that the measured values of PROG in males were relatively high in rat plasma (8–10 ng/ml for sham-operated animals), compared with normal levels, which are generally around 1–2 ng/ml (16, 27, 34). This increase in PROG levels could be due to a stress-protective reaction in response to the sham operation. The most likely hypothesis is that surgery activates the hypothalamo-pituitary-adrenal axis and stimulates the secretion of corticosterone, the final metabolite of PREG, PROG, and 11-deoxycorticosterone. Indeed, the measured levels of corticosterone in sham-operated male rats (76.8 and 52.8 ng/ml 6 and 24 h after the sham operation) indicated that the animals were stressed. Mass spectrometric studies have shown that the corticosterone levels of unstressed rats ranged from 4 to 12 ng/ml (35) and 17.1 ng/ml (36) and from 70 to 300 ng/ml for acute or chronic stress. The decrease in corticosterone levels and also in PREG, PROG, and 5{alpha}-DHPROG in plasma of sham-operated male rats 24 h after the surgery, compared with 6 h, is consistent with the acute stress hypothesis. The same tendency is found in pseudopregnant female rats for corticosterone, PREG, and PROG levels in plasma. Previous studies have shown that various types of stress lead to an increase in the brain levels of 3{alpha},5{alpha}-THPROG and/or its precursors, PREG, PROG, and 5{alpha}-DHPROG (37, 38, 39, 40).

Levels of {Delta}4-androstenedione and testosterone in brain of sham-operated male rats were slightly higher at 24 than at 6 h after surgery. The relatively low levels at 6 h may be due to the stress in response to the sham operation, which is also attested by the increased levels of PROG and corticosterone at this time point.

Predictably, 17ß-estradiol levels in brain and plasma of male and pseudopregnant female rats were below detectable limits of the technique. Indeed, using liquid chromatography/tandem mass spectrometry, 17ß-estradiol could not be detected in serum and brain of male and female mice (41). In the pseudopregnant female rats, the expected concentration of 17ß-estradiol in plasma are very low. The levels, measured by RIA, were within the range of those of metestrus (about 5–7 pg/ml plasma, which is the limit of detection of our technique) (42, 43, 44).

At the time of injury, there are differences between males and pseudopregnant females in the brain steroid profiles, which may account for the better outcome of pseudopregnant females, compared with males after TBI. Pseudopregnant females have high levels of PROG and its 5{alpha}-reduced metabolites, which have been demonstrated to be neuroprotective. Males have low levels of PROG, its precursor, and its reduced metabolites and significant levels of testosterone, its precursor, and its metabolites.

Effect of TBI on steroid levels in male and pseudopregnant females
In addition to differences in the steroid profiles in the brain at the time of injury, the subsequent effects of TBI on plasma and brain steroid levels in males and pseudopregnant females are different. Six hours after TBI, the injury induced an increase of 5{alpha}-DHPROG and 3ß,5{alpha}-THPROG in brain of pseudopregnant females and PREG, PROG, and 5{alpha}-DHPROG in brain of male rats. The increases of PREG and PROG levels in plasma of males were not statistically significant. In males, injury led to an increase in both the synthesis and metabolism of PROG. It is possible that an activation of the hypothalamo-pituitary-adrenal axis by the stress caused by TBI led to the stimulation of PREG, PROG, and corticosterone secretion in the blood and to a subsequent accumulation in the brain. The increase of PREG and PROG in male brain may also be due to a local brain increase in steroidogenic enzyme activities and/or an up-regulation of the proteins involved in the intramitochondrial transport of cholesterol, the rate-limiting step in steroidogenesis, such as steroidogenic acute regulatory protein and peripheral benzodiazepine receptor. Indeed, peripheral benzodiazepine receptor and steroidogenic acute regulatory protein have been shown to be up-regulated in different models of nervous system injuries including TBI (45, 46, 47, 48, 49).

The rate of increase of 5{alpha}-DHPROG in the injured brain was more substantial in males (+189% in the lesion site, +145% distal to the lesion site) than pseudopregnant females (+59% in the lesion site). Because 5{alpha}-DHPROG and its metabolite could have neuroprotective effects after TBI (7, 8), the stimulation of 5{alpha}-DHPROG production may be more necessary in males than pseudopregnant females because the absolute values of brain 5{alpha}-DHPROG levels are 100 times higher in pseudopregnant females than males. The observed increase of 5{alpha}-DHPROG levels in the brain of both males and pseudopregnant females after TBI is very likely due to an increase in its local synthesis because the increase in brain levels is not correlated with an increase in plasma levels, and the observed increase was not homogeneous for all brain regions. Twenty-four hours after TBI, most steroid levels in brain and plasma were similar to those in sham-operated animals, suggesting a transitory effect of TBI on steroid levels. A previous report showed an increase in PROG, 5{alpha}-DHPROG, and 3{alpha},5{alpha}-THPROG in male rat cerebral cortex after lateral fluid percussion (50). The increase was observed in the perifocal but not focal site. However, in this study there was no information concerning plasma steroid levels, and the measurements were done after infusion of large PREG-sulfate amounts, thus providing no information concerning changes in endogenous steroids.

Recently we have shown in male rats an increase in PROG, 5{alpha}-DHPROG, and 3{alpha},5{alpha}-THPROG levels after spinal cord injury (16). Thus, the increase of PROG and its reduced metabolites in the male rat nervous system may be a general mechanism that could play a pivotal role in the capacity of the nervous system to respond to the consequences of injury. The 5{alpha}-reduction of PROG yielding to 5{alpha}-DHPROG then to 3{alpha},5{alpha}-THPROG seems to be a major metabolic pathway of PROG in the nervous system. The 5{alpha}-reduction is the highest rate-limiting step in this pathway (51, 52). This pathway is activated after TBI (our present study) and spinal cord injury (16). These observations suggest that the local reduction of PROG in brain and spinal cord may be of particular relevance after injury and raise the question of the role of the metabolite reduction of PROG in the injured nervous system. Like our previous results for the spinal cord (16), the present results showed a high correlation between the levels of the product 5{alpha}-DHPROG and its precursor PROG. Indeed, in male rats, when levels of PROG were low, the levels of 5{alpha}-DHPROG measured in spinal cord and brain were low. When PROG levels were high, after treatment of males with PROG or after induction of pseudopregnancy, there was a high production of 5{alpha}-DHPROG and a subsequent 3ß,5{alpha}-THPROG formation. The type 1 isoenzyme of 5{alpha}-reductase has apparent Michaelis constant (Km) values for steroid substrate in the micromolar range, whereas the Km of type 2 is in the nanomolar range. If we take into account the levels of PROG present in brain and spinal cord and the Km of these isoenzymes (53), it can be speculated that, in male rats, the 5{alpha}-reductase type 2 is the most reactive enzyme, whereas both isoenzymes 1 and 2 of 5{alpha}-reductase may contribute to the 5{alpha}-DHPROG synthesis after treatment with PROG and in pseudopregnant females.

The effects of PROG and its reduced metabolites can be mediated by the intracellular receptors, progesterone receptor (PR; PROG and 5{alpha}-DHPROG) or membrane receptors [25-Dx (54); PR (55, 56)], or interaction with {gamma}-aminobutyric acidA receptors via 3{alpha},5{alpha}-THPROG (57). 3ß,5{alpha}-THPROG may antagonize the effects of 3{alpha},5{alpha}-THPROG (58, 59, 60). The overall effects in the nervous system may be dependent on the available amounts of the steroids on the expression pattern of the different receptors and the binding affinity of each receptor system. After injury, 5{alpha}-DHPROG levels increased in spinal cord and brain of both males and females. This increase may be of high physiological importance because 5{alpha}-DHPROG can activate the PR (61) and it is the precursor of 3{alpha},5{alpha}-THPROG and its isomer 3ß,5{alpha}-THPROG. 3{alpha},5{alpha}-THPROG has been shown to be neuroprotective after TBI (62), promote neuronal survival (63, 64), and regulate the proliferation of neural progenitors (65, 66). 5{alpha}-pregnane steroids interact with {gamma}-aminobutyric acidA receptors (67, 68) but can also interact with the PR (61, 69). The increase in the rate of conversion of PROG to its reduced metabolites in the injured nervous system may increase the cross-talk mechanism between membrane and genomic PROG effects.

In male rats, in addition to stimulating PROG synthesis and metabolism, the injury induced an important transient decrease of testosterone in brain and plasma 6 h after TBI. This decrease could be due to a disruption of the hypothalamo-pituitary-gonadal axis. Indeed, in men, endocrine deficits are rather common after TBI, and isolated hypotestosteronemia is frequent. Analysis of posttraumatic endocrine deficits in a series of severe TBIs showed an incidence of 28% of hypotestosteronemia. All were of central origin (low testosterone and low or normal LH) due to hypothalamic or pituitary origin (70). Hypothalamic hypogonadism after head injury has been reported by other authors (71, 72, 73). A decrease in serum levels of testosterone was also reported in spinal cord-injured men (74). In addition to the disruption of the hypothalamo-pituitary-gonadal axis, the observed decrease of testosterone in brain and plasma could also be due in part to the increased levels of 5{alpha}-DHPROG. Indeed, 5{alpha}-DHPROG, which is not involved in the biosynthesis pathway of testosterone, may be a substrate for P450c17 enzyme (75, 76) as well as PREG and PROG, which are precursors of testosterone (Fig. 1Go). Thus, the increased levels of 5{alpha}-DHPROG after TBI may lead to an inhibitory competition for P450c17 binding, causing a decrease in testosterone synthesis. This hypothesis is supported by the decreased plasma levels of {Delta}4-androstenedione, the direct precursor of testosterone. Finally, the observed decrease in testosterone may be a consequence of the stress caused by TBI. Indeed, several studies have shown that stress impaired steroidogenesis and induced a reduction of testicular and circulating testosterone by affecting the activity of P450c17 (77, 78, 79).

In conclusion, we have shown a substantial difference in levels of PROG and its reduced metabolites in brain and plasma of male and pseudopregnant female rats, which could account for the better outcome from TBI in pseudopregnant females, compared with males. Six hours after TBI, the brain levels of 5{alpha}-DHPROG increased in both males and pseudopregnant females, suggesting that the local reduction of PROG in brain may be of particular relevance after TBI and raising the question of its role in the injured nervous system.


   Acknowledgments
 
We thank Robert Simkins and Melissa Arellano for their excellent technical assistance.


   Footnotes
 
This work was partly supported by l’Institut pour la Recherche sur la Moelle Épinière et l’Encephale (projet: R05024L, allocation: RPS05007LLA) and National Institutes of Health Grants 1R01N540825 and 1R01N538664.

Disclosure Statement: D.M., A.P., P.L., B.E., A.C., M.S., D.G.S., and R.G. have nothing to declare.

First Published Online February 15, 2007

1 D.M. and A.P. contributed equally to this work. Back

Abbreviations: AL, Adjacent to the lesion; CNS, central nervous system; DHEA, dehydroepiandrosterone; 5{alpha}-DHPROG, 5{alpha}-dihydroprogesterone; 5{alpha}-DHT, 5{alpha}-dihydrotestosterone; DL, distal to the lesion; GC/MS, gas chromatography coupled to mass spectrometry; 3{alpha}-HSD, 3{alpha}-hydroxysteroid oxidoreductase; 3ß-HSD, 3ß-hydroxysteroid dehydrogenase; 3ß-HSOR, 3ß-hydroxysteroid oxidoreductase; Km, apparent Michaelis constant; L, lesion site; mPR, membrane PR; PR, progesterone receptor; PREG, pregnenolone; PROG, progesterone; SIM, single ion monitoring; TBI, traumatic brain injury; 3{alpha},5{alpha}-THPROG, 3{alpha},5{alpha}- tetrahydroprogesterone; 3ß,5{alpha}-THPROG, 3ß,5{alpha}-tetrahydroprogesterone; 3{alpha},5{alpha}-THT, 3{alpha},5{alpha}-tetrahydrotestosterone; 3ß,5{alpha}-THT, 3ß,5{alpha}- tetrahydrotestosterone.

Received December 19, 2006.

Accepted for publication February 7, 2007.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. McEwen BS 1981 Neural gonadal steroid actions. Science 211:1303–1311[Abstract/Free Full Text]
  2. McEwen BS 1994 Steroid hormone actions on the brain: when is the genome involved? Horm Behav 28:396–405[CrossRef][Medline]
  3. Fink G, Rosie R, Sheward WJ, Thomson E, Wilson H 1991 Steroid control of central neuronal interactions and function. J Steroid Biochem Mol Biol 40:123–132[CrossRef][Medline]
  4. Naftolin F 1994 Brain aromatization of androgens. J Reprod Med 39:257–261[Medline]
  5. Baulieu EE 1997 Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res 52:1–32[Medline]
  6. Garcia-Segura LM, Azcoitia I, DonCarlos LL 2001 Neuroprotection by estradiol. Prog Neurobiol 63:29–60[CrossRef][Medline]
  7. Stein DG 2001 Brain damage, sex hormones and recovery: a new role for progesterone and estrogen? Trends Neurosci 24:386–391[CrossRef][Medline]
  8. Stein DG 2005 The case for progesterone. Ann NY Acad Sci 1052:152–169[Abstract/Free Full Text]
  9. Schumacher M, Guennoun R, Robert F, Carelli C, Gago N, Ghoumari A, Gonzalez Deniselle MC, Gonzalez SL, Ibanez C, Labombarda F, Coirini H, Baulieu EE, De Nicola AF 2004 Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm IGF Res 14(Suppl A):S18–s33
  10. Garcia-Ovejero D, Azcoitia I, Doncarlos LL, Melcangi RC, Garcia-Segura LM 2005 Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones. Brain Res Brain Res Rev 48:273–286[CrossRef][Medline]
  11. De Nicola AF, Gonzalez SL, Labombarda F, Deniselle MC, Garay L, Guennoun R, Schumacher M 2006 Progesterone treatment of spinal cord injury: Effects on receptors, neurotrophins, and myelination. J Mol Neurosci 28:3–15[CrossRef][Medline]
  12. Guennoun R, De Nicola AF, Schumacher M, Baulieu EE 2003 Progesterone in the nervous system: an old player in new roles. In: Genazzani A, ed. Hormone replacement therapy and neurological function. London: Parthenon Publishing; 57–71
  13. Wright DW, Kellermann AL, Hertzberg VS, Clark PL, Frankel M, Goldstein FC, Salomone JP, Dent LL, Harris OA, Ander DS, Lowery DW, Patel MM, Denson DD, Gordon AB, Wald MM, Gupta S, Hoffman SW, Stein DG, ProTECT: A Randomized Clinical Trial of Progesterone for Acute Traumatic Brain Injury. Ann Emerg Med, in press
  14. Attella MJ, Nattinville A, Stein DG 1987 Hormonal state affects recovery from frontal cortex lesions in adult female rats. Behav Neural Biol 48:352–367[CrossRef][Medline]
  15. Roof RL, Duvdevani R, Stein DG 1993 Gender influences outcome of brain injury: progesterone plays a protective role. Brain Res 607:333–336[CrossRef][Medline]
  16. Labombarda F, Pianos A, Liere P, Eychenne B, Gonzalez S, Cambourg A, De Nicola AF, Schumacher M, Guennoun R 2006 Injury elicited increase in spinal cord neurosteroid content analyzed by gas chromatography mass spectrometry. Endocrinology 147:1847–1859[Abstract/Free Full Text]
  17. Meffre D, Delespierre B, Gouezou M, Leclerc P, Vinson GP, Schumacher M, Stein DG, Guennoun R 2005 The membrane-associated progesterone-binding protein 25-Dx is expressed in brain regions involved in water homeostasis and is up-regulated after traumatic brain injury. J Neurochem 93:1314–1326[CrossRef][Medline]
  18. Coirini H, Gouezou M, Liere P, Delespierre B, Pianos A, Eychenne B, Schumacher M, Guennoun R 2002 3 ß-Hydroxysteroid dehydrogenase expression in rat spinal cord. Neuroscience 113:883–891[CrossRef][Medline]
  19. Soma KK, Sinchak K, Lakhter A, Schlinger BA, Micevych PE 2005 Neurosteroids and female reproduction: estrogen increases 3ß-HSD mRNA and activity in rat hypothalamus. Endocrinology 146:4386–4390[Abstract/Free Full Text]
  20. Sinchak K, Mills RH, Tao L, LaPolt P, Lu JK, Micevych P 2003 Estrogen induces de novo progesterone synthesis in astrocytes. Dev Neurosci 25:343–348[CrossRef][Medline]
  21. Micevych PE, Chaban V, Ogi J, Dewing P, Lu JK, Sinchak K 2007 Estradiol stimulates progesterone synthesis in hypothalamic astrocyte cultures. Endocrinology 148:782–789[Abstract/Free Full Text]
  22. Billiar RB, Little B, Kline I, Reier P, Takaoka Y, White RJ 1975 The metabolic clearance rate, head and brain extractions, and brain distribution and metabolism of progesterone in the anesthetized, female monkey (Macaca mulatta). Brain Res 94:99–113[CrossRef][Medline]
  23. Schumacher M, Guennoun R, Mercier G, Desarnaud F, Lacor P, Benavides J, Ferzaz B, Robert F, Baulieu EE 2001 Progesterone synthesis and myelin formation in peripheral nerves. Brain Res Brain Res Rev 37:343–359[CrossRef][Medline]
  24. Barnea A, Hajibeigi A, Trant JM, Mason JI 1990 Expression of steroid metabolizing enzymes by aggregating fetal brain cells in culture: a model for developmental regulation of the progesterone 5{alpha}-reductase pathway. Endocrinology 127:500–502[Abstract]
  25. Martini L, Melcangi RC, Maggi R 1993 Androgen and progesterone metabolism in the central and peripheral nervous system. J Steroid Biochem Mol Biol 47:195–205[CrossRef][Medline]
  26. Hoffman SW, Fulop Z, Stein DG 1994 Bilateral frontal cortical contusion in rats: behavioral and anatomic consequences. J Neurotrauma 11:417–431[Medline]
  27. Liere P, Akwa Y, Weill-Engerer S, Eychenne B, Pianos A, Robel P, Sjovall J, Schumacher M, Baulieu EE 2000 Validation of an analytical procedure to measure trace amounts of neurosteroids in brain tissue by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl 739:301–312[CrossRef][Medline]
  28. Liere P, Pianos A, Eychenne B, Cambourg A, Liu S, Griffiths W, Schumacher M, Sjovall J, Baulieu EE 2004 Novel lipoidal derivatives of pregnenolone and dehydroepiandrosterone and absence of their sulfated counterparts in rodent brain. J Lipid Res 45:2287–2302[Abstract/Free Full Text]
  29. Corpechot C, Young J, Calvel M, Wehrey C, Veltz JN, Touyer G, Mouren M, Prasad VV, Banner C, Sjovall J, Baulieu EE, Robel P 1993 Neurosteroids: 3{alpha}-hydroxy-5{alpha}-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology 133:1003–1009[Abstract]
  30. Bixo M, Andersson A, Winblad B, Purdy RH, Backstrom T 1997 Progesterone, 5{alpha}-pregnane-3,20-dione and 3{alpha}-hydroxy-5{alpha}-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res 764:173–178[CrossRef][Medline]
  31. Cheney DL, Uzunov D, Costa E, Guidotti A 1995 Gas chromatographic-mass fragmentographic quantitation of 3{alpha}-hydroxy-5{alpha}-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats. J Neurosci 15:4641–4650[Abstract]
  32. Ebner MJ, Corol DI, Havlikova H, Honour JW, Fry JP 2006 Identification of neuroactive steroids and their precursors and metabolites in adult male rat brain. Endocrinology 147:179–190[Abstract/Free Full Text]
  33. Huang XF, Luu-The V 2000 Molecular characterization of a first human 3({alpha}–>ß)-hydroxysteroid epimerase. J Biol Chem 275:29452–29457[Abstract/Free Full Text]
  34. Verleye M, Akwa Y, Liere P, Ladurelle N, Pianos A, Eychenne B, Schumacher M, Gillardin JM 2005 The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain. Pharmacol Biochem Behav 82:712–720[CrossRef][Medline]
  35. Marwah A, Marwah P, Lardy H 2001 Liquid chromatography-electrospray ionization mass spectrometric analysis of corticosterone in rat plasma using selected ion monitoring. J Chromatogr B Biomed Sci Appl 757:333–342[CrossRef][Medline]
  36. Shu PY, Chou SH, Lin CH 2003 Determination of corticosterone in rat and mouse plasma by gas chromatography-selected ion monitoring mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 783:93–101[CrossRef][Medline]
  37. Vallee M, Rivera JD, Koob GF, Purdy RH, Fitzgerald RL 2000 Quantification of neurosteroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography/mass spectrometry. Anal Biochem 287:153–166[CrossRef][Medline]
  38. Barbaccia ML, Serra M, Purdy RH, Biggio G 2001 Stress and neuroactive steroids. Int Rev Neurobiol 46:243–272[Medline]
  39. Barbaccia ML, Roscetti G, Trabucchi M, Mostallino MC, Concas A, Purdy RH, Biggio G 1996 Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress. Neuroendocrinology 63:166–172[Medline]
  40. Higashi T, Takido N, Shimada K 2005 Studies on neurosteroids XVII. Analysis of stress-induced changes in neurosteroid levels in rat brains using liquid chromatography-electron capture atmospheric pressure chemical ionization-mass spectrometry. Steroids 70:1–11[CrossRef][Medline]
  41. Toran-Allerand CD, Tinnikov AA, Singh RJ, Nethrapalli IS 2005 17{alpha}-estradiol: a brain-active estrogen? Endocrinology 146:3843–3850[Abstract/Free Full Text]
  42. Welschen R, Osman P, Dullaart J, de Greef WJ, Uilenbroek JT, de Jong FH 1975 Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17ß and progesterone, and follicular growth in the pseudopregnant rat. J Endocrinol 64:37–47[Abstract]
  43. Smith MS, Freeman ME, Neill JD 1975 The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology 96:219–226[Abstract]
  44. Garland HO, Atherton JC, Baylis C, Morgan MR, Milne CM 1987 Hormone profiles for progesterone, oestradiol, prolactin, plasma renin activity, aldosterone and corticosterone during pregnancy and pseudopregnancy in two strains of rat: correlation with renal studies. J Endocrinol 113:435–444[Abstract]
  45. Lacor P, Benavides J, Ferzaz B 1996 Enhanced expression of the peripheral benzodiazepine receptor (PBR) and its endogenous ligand octadecaneuropeptide (ODN) in the regenerating adult rat sciatic nerve. Neurosci Lett 220:61–65[CrossRef][Medline]
  46. Lacor P, Gandolfo P, Tonon MC, Brault E, Dalibert I, Schumacher M, Benavides J, Ferzaz B 1999 Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration: a role for PBR in neurosteroidogenesis. Brain Res 815:70–80[CrossRef][Medline]
  47. Mills CD, Bitler JL, Woolf CJ 2005 Role of the peripheral benzodiazepine receptor in sensory neuron regeneration. Mol Cell Neurosci 30:228–237[CrossRef][Medline]
  48. Raghavendra Rao VL, Dogan A, Bowen KK, Dempsey RJ 2000 Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus. Exp Neurol 161:102–114[CrossRef][Medline]
  49. Sierra A, Lavaque E, Perez-Martin M, Azcoitia I, Hales DB, Garcia-Segura LM 2003 Steroidogenic acute regulatory protein in the rat brain: cellular distribution, developmental regulation and overexpression after injury. Eur J Neurosci 18:1458–1467[CrossRef][Medline]
  50. di Michele F, Lekieffre D, Pasini A, Bernardi G, Benavides J, Romeo E 2000 Increased neurosteroids synthesis after brain and spinal cord injury in rats. Neurosci Lett 284:65–68[CrossRef][Medline]
  51. Karavolas HJ, Hodges DR 1990 Neuroendocrine metabolism of progesterone and related progestins. Ciba Found Symp 153:22–44; discussion 44–55[Medline]
  52. Dong E, Matsumoto K, Uzunova V, Sugaya I, Takahata H, Nomura H, Watanabe H, Costa E, Guidotti A 2001 Brain 5{alpha}-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc Natl Acad Sci USA 98:2849–2854[Abstract/Free Full Text]
  53. Normington K, Russell DW 1992 Tissue distribution and kinetic characteristics of rat steroid 5{alpha}-reductase isozymes. Evidence for distinct physiological functions. J Biol Chem 267:19548–19554[Abstract/Free Full Text]
  54. Selmin O, Lucier GW, Clark GC, Tritscher AM, Vanden Heuvel JP, Gastel JA, Walker NJ, Sutter TR, Bell DA 1996 Isolation and characterization of a novel gene induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Carcinogenesis 17:2609–2615[Abstract/Free Full Text]
  55. Zhu Y, Bond J, Thomas P 2003 Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA 100:2237–2242[Abstract/Free Full Text]
  56. Zhu Y, Rice CD, Pang Y, Pace M, Thomas P 2003 Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci USA 100:2231–2236[Abstract/Free Full Text]
  57. Belelli D, Lambert JJ 2005 Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci 6:565–575[CrossRef][Medline]
  58. Backstrom T, Wahlstrom G, Wahlstrom K, Zhu D, Wang MD 2005 Isoallopregnanolone: an antagonist to the anaesthetic effect of allopregnanolone in male rats. Eur J Pharmacol 512:15–21[CrossRef][Medline]
  59. Lundgren P, Stromberg J, Backstrom T, Wang M 2003 Allopregnanolone-stimulated GABA-mediated chloride ion flux is inhibited by 3ß-hydroxy-5{alpha}-pregnan-20-one (isoallopregnanolone). Brain Res 982:45–53[CrossRef][Medline]
  60. Wang M, He Y, Eisenman LN, Fields C, Zeng CM, Mathews J, Benz A, Fu T, Zorumski E, Steinbach JH, Covey DF, Zorumski CF, Mennerick S 2002 3ß-hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists. J Neurosci 22:3366–3375[Abstract/Free Full Text]
  61. Rupprecht R, Reul JM, Trapp T, van Steensel B, Wetzel C, Damm K, Zieglgansberger W, Holsboer F 1993 Progesterone receptor-mediated effects of neuroactive steroids. Neuron 11:523–530[CrossRef][Medline]
  62. He J, Hoffman SW, Stein DG 2004 Allopregnanolone, a progesterone metabolite, enhances behavioral recovery and decreases neuronal loss after traumatic brain injury. Restor Neurol Neurosci 22:19–31[Medline]
  63. Ciriza I, Azcoitia I, Garcia-Segura LM 2004 Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo. J Neuroendocrinol 16:58–63[CrossRef][Medline]
  64. Griffin LD, Gong W, Verot L, Mellon SH 2004 Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat Med 10:704–711[CrossRef][Medline]
  65. Gago N, El-Etr M, Sananes N, Cadepond F, Samuel D, Avellana-Adalid V, Baron-Van Evercooren A, Schumacher M 2004 3{alpha},5{alpha}-Tetrahy